*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Dapagliflozin is a potent <strong>SGLT2 inhibitor</strong> used in pharmaceutical manufacturing. Its core synthesis involves complex organic coupling reactions. Molecular formula: <strong>C18H21FO5</strong>. CAS No: <strong>947068-26-6</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceuticals:</strong> Active Pharmaceutical Ingredient (API) for type 2 diabetes management.</li>
<li><strong>Metabolic Research:</strong> Clinical trials for cardiovascular risk reduction and kidney protection.</li>
<li><strong>Formulation:</strong> Component in fixed-dose combination tablets with metformin or other agents.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly contraindicated in severe renal impairment and end-stage renal disease. Storage requires controlled temperature below 25°C with low humidity to prevent hydrolysis. Personnel must use PPE due to potential reproductive toxicity.</p>